Literature DB >> 30723292

Phenotypical diversity of airway morphology in chronic lung graft vs. host disease after stem cell transplantation.

Stijn E Verleden1, John E McDonough2, Helene Schoemans3, Christiane Knoop4, Johny Verschakelen5, Adriana Dubbeldam5, Matthieu N Boone6, Luc Van Hoorebeke6, Erik Verbeken5, Birgit Weynand5, Dirk Van Raemdonck2, Geert M Verleden2, Robin Vos2, Bart M Vanaudenaerde2.   

Abstract

Pulmonary graft vs. host disease is a diverse and underestimated complication following allogenic hematopoietic stem cell transplantation. We aimed to compare the airway architecture with chronic lung allograft dysfunction post lung transplantation. Inflated explant lungs from graft vs. host disease patients were compared with lungs with chronic lung allograft dysfunction following lung transplantation, and control lungs using a combination of CT, microCT, and histology (n = 6 per group) and pathology in the (small) airways was further quantified and analyzed. Following allogenic hematopoietic stem cell transplantation, three patients presented as bronchiolitis obliterans syndrome and three patients showed interstitial changes and restriction. The CT analysis demonstrated a strong similarity between bronchiolitis obliterans syndrome after lung transplantation and post allogenic hematopoietic stem cell transplantation, evidenced by severe ( > 50%) airway obstruction from generation 9, with 70.8% of the airways ending in obstruction. Further analysis indicated that the airways either collapsed or accumulated matrix along a segment of the airway. In patients with restriction and interstitial changes following allogenic hematopoietic stem cell transplantation, the degree of airway obstruction was lower compared with bronchiolitis obliterans syndrome post allogenic hematopoietic stem cell transplantation, but similar to restrictive allograft syndrome post lung transplantation, showing a lower proportion of airway obstruction (20-35%), decreased number of terminal bronchioles per lung (p < 0.01), and parenchymal fibrosis. We observed similarities in the airway and parenchymal morphometric changes in lung graft vs. host disease and with chronic lung allograft dysfunction following lung transplantation, suggesting similar pathophysiological mechanisms.

Entities:  

Mesh:

Year:  2019        PMID: 30723292     DOI: 10.1038/s41379-019-0203-2

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  5 in total

1.  Noninfectious complications of hematopoietic cell transplantation.

Authors:  Kirsten M Williams
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

2.  Microbial Community Composition in Explanted Cystic Fibrosis and Control Donor Lungs.

Authors:  Gisli G Einarsson; Bart M Vanaudenaerde; Christopher D Spence; Andrew J Lee; Mieke Boon; Geert M Verleden; J Stuart Elborn; Lieven J Dupont; Dirk Van Raemdonck; Deirdre F Gilpin; Robin Vos; Stijn E Verleden; Michael M Tunney
Journal:  Front Cell Infect Microbiol       Date:  2022-03-16       Impact factor: 5.293

3.  From Macroscopy to Ultrastructure: An Integrative Approach to Pulmonary Pathology.

Authors:  Stijn E Verleden; Peter Braubach; Christopher Werlein; Edith Plucinski; Mark P Kuhnel; Annemiek Snoeckx; Haroun El Addouli; Tobias Welte; Axel Haverich; Florian P Laenger; Sabine Dettmer; Patrick Pauwels; Veronique Verplancke; Paul E Van Schil; Therese Lapperre; Johanna M Kwakkel-Van-Erp; Maximilian Ackermann; Jeroen M H Hendriks; Danny Jonigk
Journal:  Front Med (Lausanne)       Date:  2022-03-16

Review 4.  Bronchiolitis obliterans syndrome after lung or haematopoietic stem cell transplantation: current management and future directions.

Authors:  Allan R Glanville; Christian Benden; Anne Bergeron; Guang-Shing Cheng; Jens Gottlieb; Erika D Lease; Michael Perch; Jamie L Todd; Kirsten M Williams; Geert M Verleden
Journal:  ERJ Open Res       Date:  2022-07-25

Review 5.  Effector immune cells in chronic lung allograft dysfunction: A systematic review.

Authors:  Saskia Bos; Andrew J Filby; Robin Vos; Andrew J Fisher
Journal:  Immunology       Date:  2022-03-01       Impact factor: 7.215

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.